Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Kapil G Kapoor"'
Publikováno v:
Indian Journal of Ophthalmology, Vol 62, Iss 4, Pp 396-399 (2014)
Purpose: To evaluate the efficacy of combined treatment with intravitreal bevacizumab (IVB) and triamcinolone acetate (IVT) for patients with macular edema secondary to branch retinal vein occlusion (BRVO). Materials and Methods: Retrospective analys
Externí odkaz:
https://doaj.org/article/626eb7afabff42729dc1a4b71e338e22
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Laser skin resurfacing is a popular cosmetic procedure for noninvasive skin rejuvenation. Since health insurance plans often do not cover these types of procedures, patients often pay out of pocket. Consequently, there is an incen
Externí odkaz:
https://doaj.org/article/4d2f815b192741d4b700557d982fa59e
Publikováno v:
Indian Journal of Ophthalmology, Vol 61, Iss 4, Pp 186-186 (2013)
Externí odkaz:
https://doaj.org/article/baa4623b652a4f73ac1740df36a55396
Publikováno v:
Journal of the American Academy of Dermatology. 85:1571-1573
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38db730eee7df1d60ddc057a21fa6a0c
https://doi.org/10.1016/j.jaad.2019.05.067
https://doi.org/10.1016/j.jaad.2019.05.067
Autor:
James Brian Colchao, Kapil G. Kapoor
Publikováno v:
RETINAL Cases & Brief Reports. 14:200-202
The objective of this study was to evaluate patient safety and tolerance of consecutive bilateral intravitreal dexamethasone (Ozurdex) injections during a single visit for the treatment of cystoid macular edema secondary to retinal vein occlusion, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d99f29153cb38265f7bf6ebcf144f5b
https://doi.org/10.1097/icb.0000000000000653
https://doi.org/10.1097/icb.0000000000000653
Publikováno v:
Seminars in Ophthalmology. 34:420-435
Background: Age-related macular degeneration is the leading cause of blindness in adults over the age of 50 in the United States of America. Neovascular age-related macular degeneration (nAMD) is sight-threatening, but can be treated by three current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20295e9626384a6f1c20272387d699d8
https://doi.org/10.1080/08820538.2019.1641526
https://doi.org/10.1080/08820538.2019.1641526
Publikováno v:
Seminars in ophthalmology. 36(1-2)
The purpose of this study is to determine if ziv-aflibercept is a safe and effective maintenance drug for nAMD.This is a randomized, prospective, single-blinded trial. Inclusion criteria were active nAMD, prior anti-VEGF treatment, and BCVA ≤20/200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb67583cb33dad326430d184a816588
https://pubmed.ncbi.nlm.nih.gov/33577373
https://pubmed.ncbi.nlm.nih.gov/33577373
Autor:
Kapil G. Kapoor, Haley D'Souza
Publikováno v:
Current opinion in ophthalmology. 31(6)
Purpose of review The aim of this article is to summarize up-to-date research on the effects of obstructive sleep apnea (OSA) on retinal vascular conditions. Recent findings OSA is associated with the development of diabetic retinopathy, retinal vein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6ef38d11eba61c630eed261480b98f
https://pubmed.ncbi.nlm.nih.gov/33009084
https://pubmed.ncbi.nlm.nih.gov/33009084
Autor:
Jennifer Sim, Kapil G. Kapoor
Publikováno v:
Case Reports in Ophthalmology
Case Reports in Ophthalmology, Vol 8, Iss 2, Pp 314-320 (2017)
Case Reports in Ophthalmology, Vol 8, Iss 2, Pp 314-320 (2017)
Neovascular age-related macular degeneration (AMD) is a potentially sight-threatening condition. The current standard-of-care treatment regimen is serial intravitreal antivascular endothelial growth factor injections. While these typically have great
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c8cbf42a3a72530493fc5f9ea51cab
http://europepmc.org/articles/PMC5471798
http://europepmc.org/articles/PMC5471798
Publikováno v:
Retina. 36:552-557
BACKGROUND Limited data have evaluated multiple injections of the dexamethasone 700 μg implant (DEX) (Ozurdex; Allergan, Inc.) for cystoid macular edema (CME) secondary to retinal vein occlusion (RVO) over an extended regimen. METHODS This retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1ff6b999d0e22066657b5b803a60ad3
https://doi.org/10.1097/iae.0000000000000750
https://doi.org/10.1097/iae.0000000000000750